key: cord-0960275-ad7s0cmf
authors: Mouawad, Nicolas J.; Woo, Karen; Malgor, Rafael D.; Wohlauer, Max V.; Johnson, Adam P.; Cuff, Robert. F.; Coleman, Dawn M.; Coogan, Sheila M.; Sheahan, Malachi G.; Shalhub, Sherene
title: The impact of the COVID-19 pandemic on vascular surgery practice in the United States
date: 2020-09-01
journal: J Vasc Surg
DOI: 10.1016/j.jvs.2020.08.036
sha: 8a24a62dc2682923ee0d97192e40705bc5798e52
doc_id: 960275
cord_uid: ad7s0cmf

INTRODUCTION: The coronavirus disease 2019 (COVID-19) pandemic has led to widespread postponement and cancelation of elective surgeries in the United States. We designed and administered a global survey to examine the impact of COVID-19 on vascular surgeons. We describe the impact of the pandemic on the practices of Vascular Surgeons in the United States. METHODS: The Pandemic Practice, Anxiety, Coping, and Support Survey for Vascular Surgeons is an anonymous cross-sectional survey sponsored by the Society for Vascular Surgery Wellness Task Force disseminated April 14-24, 2020. This analysis focuses on pattern changes in vascular surgery practices in the United States including the inpatient setting, ambulatory, and vascular laboratory setting. Specific questions regarding occupational exposure to COVID-19, adequacy of personal protective equipment (PPE), elective surgical practice, changes in call schedule, and redeployment to non-vascular surgery duties were also included in the survey. Regional variation was assessed. The survey data were collected using REDCap and analyzed using descriptive statistics. RESULTS: A total of 535 vascular surgeons responded to the survey from 45 states. Most of the respondents were male (73.1%), White (70.7%), practiced in urban settings (81.7%), and in teaching hospitals (66.8%). Almost half were in hospitals with greater than 400 beds (46.4%). There was no regional variation in the presence of pre-operative COVID-19 testing, COVID-19 OR protocols, adherence to national surgical standards, and the presence of PPE. The overwhelming majority of respondents (91.7%) noted elective surgery cancellation, with the Northeast and Southeast regions having the most case cancellations 94.2% and 95.8% respectively %). The Northeast region reported the highest percentage of operations/procedures on patients with COVID-19, which was either identified at the time of the surgery or later in the hospital course (82.7%). Ambulatory visits were performed via telehealth (81.3%), with 71.1% having restricted hours. Over half of OBLs were closed, although there was regional variation with over 80% in the Midwest being closed. Cases performed in OBLs focused on critical limb ischemia (42.9%) and dialysis access maintenance (39.9%). Call schedules modifications were common, although the number of call days remained the same (45.8%). CONCLUSIONS: Vascular surgeons in the United States report substantial impact on their practices during the COVID-19 pandemic, and regional variations are demonstrated - particularly in OBL utilization, ICU bed availability, and COVID-19 exposure at work.

West/Southwest. The COVID-19 pandemic resulted in significant impact to the practice of 9 vascular surgery across the United States with unprecedented surgery cancellation, changes in 10 on-call schedules, and redeployment to non-vascular surgical duties. Regional variation was 11 noted in ICU availability, outpatient based laboratory, and COVID-19 exposure. 12

Take home Message: The COVID-19 pandemic resulted in significant impact to the practice of 13 vascular surgery across the United States with unprecedented surgical cases cancellation, 14 changes in on-call schedules, and redeployment to non-vascular surgical duties. Regional 15 variation was noted in ICU availability, outpatient based laboratory, and COVID-19 exposure 16 The global pandemic of Coronavirus Disease 2019 (COVID-19) has led to unprecedented 2 cancellation of elective surgeries in the United States and has posed a significant strain on the 3 finances of health care systems. A recent report by the CovidSurg Collaborative projects that 4 28.4 million elective surgeries worldwide will be canceled or postponed in 2020. 1 During the 5 height of the pandemic, tier classifications of surgical procedures were created to stratify the 6 urgency of operations. The goals of these classification systems were to maintain optimal patient 7 outcomes, to preserve essential equipment and resources needed to handle the volume of 8 critically ill patients, and to uphold the crucial public health guidelines for physical distancing. 2-6 9

Early reports have described the impact of these restrictions on local practice patterns amid the 10 pandemic. 7, 8 The objective of this study is to describe the vascular surgery practice pattern 11 changes in the inpatient, ambulatory, and vascular laboratory settings associated with the 12 COVID-19 pandemic in the United States during the period of April 14-24, 2020. in the United States including the inpatient setting, ambulatory, and vascular laboratory setting. 20

Additionally, questions regarding occupational exposure to COVID-19, adequacy of personal 21 protective equipment (PPE), elective surgery practices, changes in call schedules, and 22 redeployment to non-vascular surgery duties were included. The survey questions are included in 23 the supplement. The study was reviewed by the University of Washington (UW) Human 1 Subjects Division and deemed exempt (#009926) due to the minimal risk and non-identifiable 2 nature of the study. Consent by each participant was given by their individual response to the 3 survey. A multimodality approach, previously described 9 , was utilized to disseminate the survey 4 between 4/14/2020 and 4/24/2020, inclusive. Dissemination modalities included the SVS 5 membership electronic mailing lists, other organizational mailing lists, podcasts, newsletters, and 6 social media platforms (Supplement Table 1 ). The survey data were collected using a secure 7

REDCap (Research Electronic Data Capture) data capture platform hosted at the University of 8

Washington. 9,10 The data were analyzed using descriptive statistics. Categorical data are 9 presented as numbers and percentages. Continuous data are presented as means and standard 10 deviation of the mean or median and ranges or interquartile range (IQR) where appropriate. Data 11 were compared using the Student's t-test for normally distributed data and Wilcoxon rank-sum 12 test for non-normally distributed data. Categorical data were compared using the Pearson Chi-13 square test. Data were analyzed using SPSS 19.0 for Windows (SPSS, Inc., Chicago, IL). 14

A total of 535 vascular surgeons in the United States responded to the survey from 45 16 states (Figure 1) J o u r n a l P r e -p r o o f was no significant regional difference in completion rates (87.7%, 95.1%, 89.7%, and 92.6% 1 respectively, P=.16). 2

Of the 480 vascular surgeons who answered the questions regarding intensive care unit 4 (ICU) capacity, most noted that ICU beds were available at their hospital (N=402, 83.7%), while 5 others had patients boarding in the emergency department (14.6%), postoperative care unit, 6 and/or operating rooms (11%). The lack of ICU beds was most common in the Northeast region, 7

where over a quarter noted that ICU beds were at capacity, and patients were being boarded in 8 the PACU/operating room ( Table 2) . 9

The vast majority of respondents noted that all elective surgical procedures were canceled 10 (452/493, 91.2%) with no significant differences by type of hospital (92.6% teaching hospitals vs 11 89.2% non-teaching hospitals, P=.238). A small number of vascular surgeons 8.3% (41/493) 12 indicated that they were still performing elective cases focused primarily on dialysis access 13 (58.5%), followed by aortic repair (51.2%), and lower extremity revascularization (48.8%, 14 Call schedules were modified for 45.9%, with the majority noting that they had the same overall 19 number of call days in an altered distribution. Just over one-third of study participants (171, 20 34.8%) were asked to assist in duties other than those of a vascular surgeon, most frequently in 21 the Northeast region. The primary redeployment was to the ICU, and the most common re-22 appropriation duty was placement of central venous catheters (Figure 3) . 23

A total of 452/492 (91.7%) respondents indicated they had dedicated COVID-19 2 operating room protocols at their hospital, and 49% had pre-operative testing of patients for 3 COVID-19 available. Just under one-fourth of vascular surgeons (N=131; 24.5%) had either 4 operated on a patient or placed a central line (including hemodialysis catheters) on a patient with 5 a confirmed COVID-19 infection ( Table 2) . The Northeast had the most respondents who reported operating on a patient with 1 COVID-19 or who was later found to be COVID-19 positive, while the West/Southwest region 2 had the least (22.5% vs. 9.4%; P=.006). 3

The majority of vascular surgeons reported disruption to their outpatient clinic/ambulatory center 5 schedules (440/493, 89.2%). Changes included limited clinic/ambulatory center hours (350/493, 6 71%) and use of telehealth (400/493, 81.1%, Table 3 ). A total of 15 respondents (2.8%) noted 7 that due to the crisis they offered no clinic and no telehealth services. 8

Two-hundred and three respondents (47.7%) indicated that they have an office-based lab 9 (OBL). Of those, 99 (48.8%) were still open, with the majority performing urgent procedures 10 only and focused on peripheral arterial disease and dialysis access (Table 3). Regional variation 11 was identified with more OBL practices closing in the Northeast (65.2%) and Midwest (80.4) as 12 compared to the Southeast (31.5%) and West/Southwest (35.1%). 13

Most of the respondents (96.7%) have a vascular laboratory, and the majority of vascular 15 labs were performing urgent outpatient studies (351; 74.4%, Table 3 has been seen in other specialties. [11] [12] [13] [14] [15] The most common redeployment was to the ICU, as well 5 as the formation of central line teams to minimize multi-provider exposure and leverage the 6 expertise of vascular surgeons. As expected, redeployment was most common in areas most 7 affected by the pandemic, such as the Northeast region. On-call schedules were modified in 8 terms of call distribution and frequency to promote physical distancing and minimize the 9 exposure of multiple members of the team at a given time. 10

Contemporary vascular surgical practice has promoted outpatient management and 11 encouraged the use of OBLs to offload the demands of larger hospital facilities. Despite their 12 multiple benefits, changes in outpatient services were expected during this crisis, and many of 13 the vascular practices limited their OBL hours -reasons included helping to promote physical 14 distancing, minimizing provider exposure, unavailability of staff (due to financial restrictions 15 and/or furlough at large health systems), and most commonly, patients' fear of contracting 16 COVID-19 in a health care facility. Most practices converted to offering consults via telephone 17 or telemedicine/telehealth visits. The lack of in-person meetings has essentially become 18 commonplace and telehealth is becoming a "must-have" for practice viability. Interestingly, 15 19 respondents noted that their offices closed, and they offered no telehealth capabilities; this was 20 not regionally specific. Significant regional variation was identified with over 80% of OBLs in 21 the Midwest closing as compared with only 31.5% and 35.1% in the Southeast and 22 1 were the types of cases most frequently being performed in the OBL setting. 2

The majority of respondents noted a shift toward the vascular diagnostic lab performing 3 only urgent outpatient referrals and inpatient consults at their institutions. Mitigation options 4 revolved around decreasing the frequency of the vascular lab evaluations or reducing hours of 5 service. Clearly, delaying vascular pathology surveillance made many uncomfortable and options 6 to maintain such schedules were explored. Urgent outpatient studies were still being performed 7 without regional variation, although the Midwest continued to do a large proportion of inpatient 8 evaluations. 9

Several limitations exist due to the self-reported survey design, which can introduce 10 social desirability bias, recall bias, and respondent selection bias. This survey a snapshot of 10 11 days during a very dynamic situation of early COVID-19 experience, with circumstances 12 changing daily. Some of the states were on the steep part of the pandemic curve and getting 13 ready to peak, whereas others did not see large influx of infected patients at the time of survey 14 completion. In particular, a significant number of respondents to the survey were from the New 15 York, Michigan, and California, all of whom were severely affected by the pandemic during this 16 period. The majority of the respondents were from urban and teaching hospitals thus the 17 responses reflect mostly this experience. The majority of the respondents were from urban and 18 teaching hospitals thus the responses reflect mostly this experience. Also, surgeons may have 19 appointments in more than one facility, such as joint appointments with the Veteran's 20 Administration (VA). These surgeons may have selected their primary hospital rather than the 21 VA; therefore, the VA may be underrepresented. Lastly, the timing of the survey development 22

and dissemination coincided with the rapid development of practice guidelines and the common 23 language we are now all familiar with such as the Vascular Activity Condition or VASCCON 1 language or the tiers 1-3 by the ACS. 3,6 These were not incorporated in the survey design at that 2 time thus limited the detail surrounding cancelled "elective" cases. This language will be 3 included in future survey design. 4

The survey evaluated the impact of COVID-19 on vascular surgeons practicing in the United 5

States at a single point in time. Our data show that vascular surgical care and surveillance has 6 been restricted, and will likely continue to be limited as the COVID-19 pandemic continues. The 7 long-term effects on vascular patients are unknown, and the greater need for preserving public 8 health resources to the population remains a priority. The unknown sequelae of unanticipated 9 delays on vascular surgical care and patient outcomes prompted the creation of the Vascular 10 Surgery COVID-19 Collaborative (VASCC) to prospectively follow these impacts. 18 11

The COVID-19 pandemic led to dramatic changes to the delivery of vascular surgical care in the 13 United States during the period of April 14-24, 2020 and regional variations in practice patterns 14 were identified. These included significant cancellations of elective surgical cases, reduction in 15 outpatient visits, and lower utilization of the vascular lab. Vascular care was continued via 16 telemedicine and for cases favoring life-over-limb. 17 J o u r n a l P r e -p r o o f Tables   Table 1. Description of the 535 vascular surgeons who responded to the survey and their practices. Table 2 . COVID-19 occupational exposure and related changes to in-hospital surgical practice Table 3 . COVID-19 related changes in outpatient and diagnostic vascular lab services J o u r n a l P r e -p r o o f

Research electronic 1 data capture (REDCap)--a metadata-driven methodology and workflow process for 2 providing translational research informatics support

The REDCap 4 consortium: Building an international community of software platform partners

Perspectives From the Foot and Ankle Department at an Academic Orthopedic Hospital 8

During the Surge Phase of the COVID-19 Pandemic

Academic Ophthalmology during and after the COVID-19

Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak

Neurosurgical Practice During the Severe Acute Respiratory Syndrome Coronavirus 2 17 (SARS-CoV-2) Pandemic: A Worldwide Survey. World Neurosurg Published online 18 ahead of print

Strategy for the 20 practice of digestive and oncological surgery during the Covid-19 epidemic

COVID-19 Case Data

Transforming ORs into ICUs

Surgery COVID-19 Collaborative (VASCC)

Any elective cases Aortic Carotid Dialysis access Lower extremity revascularization Venous Northeast (N=121) Southeast (N=118)

Midwest (N=115) West/Southwest (N=19)